why choose us

First received: November 8, 2022

Clinical Trial: A Compassionate Use (CU) Program of Odronextamab

Condition: Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Diffuse Large B-Cell Lymphoma (DLBCL)

Study Type: Expanded Access


Official Title: Not Provided

Brief Summary: Provide compassionate use of odronextamab

Read more